IP Boom Continues at Paul Hastings with Life Sciences and Technology Partner Addition
New York, NY — Paul Hastings LLP, a leading global law firm, announced today that
“Our IP practice is a market-leading practice, which we’ve continued to strengthen on both the Life Sciences and Technology sides,” said
“Paul Hastings is the ideal platform for building my practice to its full potential,” said Mr. Peterman. “I have worked as co-counsel with several of the firm’s partners and have always been attracted to the firm’s culture and impressed with its track-record of wins and precedent-setting victories,” he added.
Mr. Peterman is a skilled IP and antitrust trial attorney with an extensive background in the Life Sciences and Technology industries. He has been involved in all phases of litigation from pre-suit investigation/strategy through appeal. Mr. Peterman has represented major software, telecommunications, semiconductor, and medical equipment companies in patent litigations. He has also represented major pharmaceutical companies in complex ANDA litigations, antitrust litigations, arbitrations, and mediations. In addition to litigation, Mr. Peterman also represents companies in intellectual property transactional matters, including rendering patent opinions and negotiating a variety of intellectual property agreements.
Mr. Peterman’s arrival not only follows Hiro Hagiwara and Hassen Sayeed, M.D., but also a ten-member technology patent trial team from McDermott, Will & Emery that included partners
Paul Hastings is regularly acknowledged for its track-record of winning major cases and setting precedents in patent law. The firm was recognized by
At Paul Hastings, our purpose is clear—to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.